2026 Psoriatic Arthritis (PsA) Research Program
Funds research to advance understanding, prevention, and treatment of psoriatic arthritis, with a focus on biomarkers, mechanisms, and improving patient outcomes.
Funder: Arthritis Foundation
Due Dates (Anticipated): May 2027: Letter of Intent deadline (projected)
Funding Amounts: Up to $250,000 total over 2 years (includes up to 8% indirect costs)
Summary: Supports innovative research to advance understanding, prevention, and treatment of psoriatic arthritis, aiming to improve patient outcomes.
Key Information: This is a forecasted opportunity; all deadlines are projected and subject to change.
Description
The Arthritis Foundation’s Psoriatic Arthritis (PsA) Research Program funds projects that advance understanding of psoriatic arthritis and improve treatment strategies, with the overarching goal of enhancing the lives of people living with PsA. The program welcomes proposals addressing a broad range of topics, including biomarkers, risk factors for PsA development, prevention, treatment, the underlying mechanisms with clinical relevance, and the impact of comorbidities on disease progression and treatment. Interdisciplinary team proposals are especially encouraged.
